Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating income | — | — | — | — | — | -$117K | -$10.3M | -$6.02M | -$1.05M |
| Net income | -$654K | -$120K | -$3.02M | $1.42M | $341K | -$1.13M | -$10.3M | -$6.28M | -$121K |
| EPS (diluted) | — | — | — | — | — | -$0.10 | -$0.13 | -$0.08 | $0.00 |
| Fiscal year | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | -$108K | -$136K | -$31.6K | -$47.3K | -$164K | -$359K | -$396K |
| Fiscal year | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | $19.0K | $15.0K | $2.06K | $475.00 | $839.00 | $71.6K | $112K | $64.5K |
| Total assets | — | — | $17.3K | $3.84K | $6.06K | $1.26K | $106K | $133K | $384K |
| Total liabilities | — | — | $2.97M | $1.03M | $681K | $55.8K | $435K | $1.61M | $429K |
| Shareholders' equity | $29.7K | $4.17K | -$2.95M | -$1.02M | -$675K | -$54.5K | -$329K | -$1.47M | -$45.4K |
| Retained earnings | — | — | — | — | $2.16M | -$4.01M | -$14.3M | -$20.6M | -$20.7M |
| Shares (wtd avg diluted) | — | — | 28.0M | 33.9M | 35.8M | 65.9M | 74.7M | 75.6M | 82.4M |
Every figure is extracted from BetterLife Pharma Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.